Learn More
Medchemexpress LLC 7030B-C5 | 370871-42-4 | 99.8% | 359.38 g/mol | C17H21N5O4 | 10 MG

Supplier: Medchemexpress LLC HY16193910MG
7030B-C5 is a small-molecule PCSK9 inhibitor intended for preclinical research. It shows in vitro activity (IC50 = 1.61 μM) and has been reported to reduce plasma cholesterol and triglyceride levels in vivo. The compound is identified by CAS No. 370871-42-4 and is supplied at high purity for laboratory studies.
- Small-molecule PCSK9 inhibitor with reported IC50 of 1.61 μM.
- Demonstrated in vivo activity reducing plasma cholesterol and triglyceride levels.
- High purity (99.78%), suitable for preclinical studies.
- Characterized molecular weight 359.38 g/mol and formula C17H21N5O4.
- Supplied as a 10 mg quantity for laboratory use.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.